ENRUHE
PF-Atlas › Clinical Trials › NCT00625079

Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil

sildenafil · Phase 4

Registry ID
NCT00625079
Phase
Phase 4
Status
Withdrawn
Drug / intervention
sildenafil
Sponsor
University of California, Los Angeles
Start
2007-02

About this trial

sildenafil is evaluated in NCT00625079, a Phase 4 idiopathic pulmonary fibrosis study sponsored by University of California, Los Angeles. Current status: Withdrawn.

View NCT00625079 on ClinicalTrials.gov →

Explore related

All sildenafil trialsAll IPF trials

Related trials

sildenafil — NCT00359736Sildenafil — NCT00352482sildenafil — NCT00659529Sildenafil — NCT01194232Sildenafil — NCT02057458Sildenafil — NCT00981747
Medical disclaimer. This page summarizes public trial data for NCT00625079 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.